The ESLHO symposium Poster Prize is rewarded every year at the ESLHO Symposium. At this 13th ESLHO Symposium, which took place in Lisbon Portugal, all poster presenters were asked to pitch their work in a short Blitz presentation to the public. This resulted in a powerful, energizing session in which the - mostly young - scientists did an excellent job in getting attention for their poster. During lunch, the public could visit the posters for more in-depth explanation and discussion. After that the visitors were asked to rate the posters by rewarding their top-three. The prize for Best Poster was for Wiebke Wessels from Kiel with her poster on Preleukemic clonal haematopoiesis in acute lymphoblastic leukaemia. Alice Darbyshire from Birmingham and Javier Morán-Plata from Salamanca came in second and third, respectively.

We are looking back on a wonderful ESLHO week in Lisbon, Portugal. All three ESLHO consortia EuroFlow, EuroClonality and EuroMRD had their general meetings. They were all very productive and there was also time to meet sociable during dinners which is so important to keep our cooperative work at the highest level. Highlight wasthe 13th ESLHO Symposium on Thursday. The historical Convento de Beato formed an almost magical background to host the symposium titled Muli-omics approaches for diagnosis and monitoring of hematological malignancies. The excellent invited speakers, the abstract-based selected speakers and the blitz- and poster presentations made it into a varied and scientifically highly interesting gathering. This open symposium was made possible by sponsors, who presented themselves in the well-visited sponsor area.

On behalf of the EuroMRD Consortium, Vincent van der Velden and Michaela Kotrova have achieved to produce two new publications. The benchmark manuscripts ‘Analysis of measurable residual disease by IG/TR gene rearrangements: QA and updated EuroMRD guidelines’ and ‘The gray area of RQ-PCR-based measurable residual disease: subdividing the positive, below quantitative range (PBQR) category’ have recently been published in Leukemia.